Financials and Filings

MGEN $7.20 $ - 0.05 (0.68%)

SEC Filings

Other Filings
Filing Description Filing Type Filing Date Event Date  
Proxy DEF 14A 5/15/2018 6/27/2018
Proxy DEFA14A 5/15/2018
8-K 8-K 5/9/2018 5/9/2018
Abstract: 8-K filed by Miragen Therapeutics (MGEN) covering Results of Operations and Financial Condition; Other Events; and Financial Statements and Exhibits.
10-Q 10-Q 5/9/2018 3/31/2018
8-K 8-K 5/8/2018 5/8/2018
Abstract: 8-K filed by Miragen Therapeutics (MGEN) covering Other Events and Financial Statements and Exhibits.
8-K 8-K 5/2/2018 5/1/2018
Abstract: 8-K filed by Miragen Therapeutics (MGEN) covering Other Events and Financial Statements and Exhibits.
8-K 8-K 4/27/2018 4/27/2018
Abstract: 8-K filed by Miragen Therapeutics (MGEN) covering Other Events and Financial Statements and Exhibits.
10-K 10-K/A 4/20/2018 12/31/2017
8-K 8-K 4/6/2018 4/3/2018
Abstract: 8-K filed by Miragen Therapeutics (MGEN) covering Entry into a Material Definitive Agreement.
8-K 8-K 3/27/2018 3/26/2018
Abstract: 8-K filed by Miragen Therapeutics (MGEN) covering Other Events and Financial Statements and Exhibits.
8-K 8-K/A 3/27/2018 1/3/2018
Abstract: 8-K filed by Miragen Therapeutics (MGEN) covering Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers.
10-K 10-K 3/15/2018 12/31/2017
Registration Statement S-8 3/15/2018
8-K 8-K 3/14/2018 3/14/2018
Abstract: 8-K filed by Miragen Therapeutics (MGEN) covering Results of Operations and Financial Condition and Financial Statements and Exhibits.
8-K 8-K 2/28/2018 2/28/2018
Abstract: 8-K filed by Miragen Therapeutics (MGEN) covering Other Events.
8-K 8-K 2/9/2018 2/8/2018
Abstract: 8-K filed by Miragen Therapeutics (MGEN) covering Regulation FD Disclosure; Other Events; and Financial Statements and Exhibits.
Prospectus 424B5 2/9/2018
8-K 8-K 2/5/2018 1/31/2018
Abstract: 8-K filed by Miragen Therapeutics (MGEN) covering Results of Operations and Financial Condition; Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers; Regulation FD Disclosure; Other Events; and Financial Statements and Exhibits.
Prospectus 424B5 2/5/2018
13-D SC 13G/A 1/30/2018

Displaying 1 to 20 (of 176 filings)